Contribute Try STAT+ Today

As a major conference on tuberculosis nears, Doctors Without Borders is pressuring suppliers of key medicines — Johnson & Johnson (JNJ), Mylan (MYL) and Otsuka Pharmaceuticals — to lower their prices by significant amounts.

As part of its effort, the nonprofit is protesting outside J&J offices in several countries to demand the health care giant slash the price of Sirturo by half — to $1 a day. Currently, the lowest price J&J charges for a 20-month treatment course is $1,200, or $2 a day, in countries eligible to buy the drug through the Global Drug Facility, a purchasing mechanism run by Stop TB Partnership, a United Nations program.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.